On the public citation graph
Molecular Interaction of Anti‐Diabetic Drugs With Acetylcholinesterase and Sodium Glucose Co‐Transporter 2
0 signed · 82 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/bab.1319openalex-snapshot
Forxiga (dapagliflozin): Plausible role in the treatment of diabetes‐associated neurological disorders
inferredcites →https://doi.org/10.1002/bip.21220openalex-snapshot
A spectroscopic investigation into the interactions of 3′‐O‐carboxy esters of thymidine with bovine serum albumin
inferredcites →https://doi.org/10.1002/elps.1150181505openalex-snapshot
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
inferredcites →https://doi.org/10.1002/jcc.21256openalex-snapshot
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
inferredcites →https://doi.org/10.1007/s00125-009-1533-2openalex-snapshot
Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors
inferredcites →https://doi.org/10.1007/s11064-016-1859-3openalex-snapshot
Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer’s Disease-Diabetes Dual Therapy
inferredcites →https://doi.org/10.1007/s11910-007-0058-7openalex-snapshot
Type 2 diabetes and risk of cognitive impairment and dementia
inferredcites →https://doi.org/10.1016/j.bpj.2008.09.045openalex-snapshot
Effects on Conformational States of the Rabbit Sodium/Glucose Cotransporter through Modulation of Polarity and Charge at Glutamine 457
inferredcites →https://doi.org/10.1016/j.dsx.2016.01.021openalex-snapshot
Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review
inferredcites →https://doi.org/10.1016/j.ejps.2016.08.025openalex-snapshot
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective
inferredcites →https://doi.org/10.1016/j.neubiorev.2016.03.005openalex-snapshot
Diabetes and Alzheimer’s disease crosstalk
inferredcites →https://doi.org/10.1038/clpt.2012.58openalex-snapshot
LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
inferredcites →https://doi.org/10.1038/nmeth.1818openalex-snapshot
HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment
inferredcites →https://doi.org/10.1038/srep25589openalex-snapshot
Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer’s Disease
inferredcites →https://doi.org/10.1093/bioinformatics/bti770openalex-snapshot
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
inferredcites →https://doi.org/10.1093/bioinformatics/btq662openalex-snapshot
Toward the estimation of the absolute quality of individual protein structure models
inferredcites →https://doi.org/10.1093/nar/gkg565openalex-snapshot
VADAR: a web server for quantitative evaluation of protein structure quality
inferredcites →https://doi.org/10.1093/nar/gkp280openalex-snapshot
GeNMR: a web server for rapid NMR-based protein structure determination
inferredcites →https://doi.org/10.1093/nar/gkq375openalex-snapshot
PROSESS: a protein structure evaluation suite and server
inferredcites →https://doi.org/10.1093/nar/gkr366openalex-snapshot
SwissDock, a protein-small molecule docking web service based on EADock DSS
inferredcites →https://doi.org/10.1093/nar/gkt380openalex-snapshot
MoMA-LigPath: a web server to simulate protein–ligand unbinding
inferredcites →https://doi.org/10.1093/nar/gku340openalex-snapshot
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
inferredcites →https://doi.org/10.1124/jpet.113.203364openalex-snapshot
LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
inferredcites →https://doi.org/10.1126/science.1160406openalex-snapshot
The Crystal Structure of a Sodium Galactose Transporter Reveals Mechanistic Insights into Na + /Sugar Symport
inferredcites →https://doi.org/10.1172/jci116972openalex-snapshot
The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.
inferredcites →https://doi.org/10.1172/jci57256openalex-snapshot
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
inferredcites →https://doi.org/10.1177/193229680800200619openalex-snapshot
Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed
inferredcites →https://doi.org/10.17179/excli2015-252openalex-snapshot
Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease
inferredcites →https://doi.org/10.2147/cia.s74042openalex-snapshot
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
inferredcites →https://doi.org/10.2174/092986611796011400openalex-snapshot
Crystallization and Preliminary X-Ray Crystallographic Analysis of CTXM- 15, an Extended-spectrum β-Lactamase Conferring Worldwide Emerging Antibiotic Resistance
inferredcites →https://doi.org/10.2174/187152711798072365openalex-snapshot
Interaction of Human Brain Acetylcholinesterase with Cyclophosphamide: A Molecular Modeling and Docking Study
inferredcites →https://doi.org/10.2174/187152712800269669openalex-snapshot
Molecular Interaction of the Antineoplastic Drug, Methotrexate with Human Brain Acetylcholinesterase: A Docking Study
inferredcites →https://doi.org/10.2174/18715273113126660143openalex-snapshot
A Neuroinformatics Study Describing Molecular Interaction of Cisplatin with Acetylcholinesterase: A Plausible Cause for Anticancer Drug Induced Neurotoxicity
inferredcites →https://doi.org/10.2174/18715273113126660160openalex-snapshot
Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer’s Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study
inferredcites →https://doi.org/10.2174/18715273113126660166openalex-snapshot
Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective
inferredcites →https://doi.org/10.2174/1871527316666170207160606openalex-snapshot
Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses
inferredcites →https://doi.org/10.3109/0954898x.2014.994145openalex-snapshot
A neuroinformatics study to compare inhibition efficiency of three natural ligands (Fawcettimine, Cernuine and Lycodine) against Human Brain Acetylcholinesterase
inferredcites →https://doi.org/10.3233/jad-2005-8304openalex-snapshot
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine
inferredcites →https://doi.org/10.6026/97320630004468openalex-snapshot
Interaction of CTX-M-15 enzyme with cefotaxime: a molecular modelling and docking study
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/hsr2.70975openalex-snapshot
Understanding the Intersection Between Hormonal Dynamics and Brain Plasticity in Alzheimer's Disease: A Narrative Review for Implementing New Therapeutic Strategies
inferred← citeshttps://doi.org/10.1002/jcb.28461openalex-snapshot
Molecular interaction of investigational ligands with human brain acetylcholinesterase
inferred← citeshttps://doi.org/10.1007/978-3-031-81728-1_4openalex-snapshot
Recent Trends and Success Stories of Computational Techniques in Drug Discovery
inferred← citeshttps://doi.org/10.1007/s11011-023-01225-3openalex-snapshot
Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs
inferred← citeshttps://doi.org/10.1007/s11011-024-01478-6openalex-snapshot
The SGLT2 inhibitor empagliflozin exerts neuroprotective effect against hydrogen peroxide-induced toxicity on primary neurons
inferred← citeshttps://doi.org/10.1016/b978-0-323-91707-0.00012-7openalex-snapshot
Insulin and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.arr.2025.102751openalex-snapshot
Reducing Alzheimer’s disease risk with SGLT2 inhibitors: From glycemic control to neuroprotection
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2022.108009openalex-snapshot
Fast approximative methods for study of ligand transport and rational design of improved enzymes for biotechnologies
inferred← citeshttps://doi.org/10.1016/j.cca.2022.12.016openalex-snapshot
Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2019.09.802openalex-snapshot
P.768 Does the Camellia sinensis plant have an therapeutic effect on cognitive deficits in diabetes-induced Alzheimer?
inferred← citeshttps://doi.org/10.1016/j.insi.2026.100673openalex-snapshot
A study on flavanomarein as a potential natural SGLT2 inhibitor through molecular docking
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2022.108966openalex-snapshot
Exploring the dual character of metformin in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.physbeh.2023.114134openalex-snapshot
The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation
inferred← citeshttps://doi.org/10.1016/j.semcancer.2017.11.004openalex-snapshot
Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy
inferred← citeshttps://doi.org/10.1021/acsptsci.0c00168openalex-snapshot
Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1038/s41598-022-22822-9openalex-snapshot
Identification of repurposed drugs targeting significant long non-coding RNAs in the cross-talk between diabetes mellitus and Alzheimer’s disease
inferred← citeshttps://doi.org/10.1080/17425255.2025.2457393openalex-snapshot
A comprehensive review of the efficacy and safety of ertugliflozin
inferred← citeshttps://doi.org/10.1097/md.0000000000039687openalex-snapshot
The role and mechanism of dapagliflozin in Alzheimer disease: A review
inferred← citeshttps://doi.org/10.1111/acel.70101openalex-snapshot
SGLT2 Inhibition by Enavogliflozin Significantly Reduces Aβ Pathology and Restores Cognitive Function via Upregulation of Microglial AMPK Signaling in 5XFAD Mouse Model of Alzheimer's Disease
inferred← citeshttps://doi.org/10.1111/ejn.70495openalex-snapshot
Modulation of Amyloid and Tau Pathology by Empagliflozin in a High‐Fat Diet and Streptozotocin‐Induced Type 2 Diabetes‐Associated Alzheimer's Model
inferred← citeshttps://doi.org/10.1186/s13195-020-00607-4openalex-snapshot
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes
inferred← citeshttps://doi.org/10.2147/ndt.s599108openalex-snapshot
Sodium-Glucose Cotransporter-2 Inhibitors in Mood Disorders: A Narrative Review of Mechanisms, Evidence, and Challenges
inferred← citeshttps://doi.org/10.2174/1381612825666190618141015openalex-snapshot
Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine
inferred← citeshttps://doi.org/10.2174/1570180820666230130093631openalex-snapshot
In vitro Cholinesterase Inhibitory Activities of Piper betle Stem and their Correlation with In silico Docking Studies of its Phytoconstituents
inferred← citeshttps://doi.org/10.2174/1573406419666230803122020openalex-snapshot
Ligand-Based and Structure-Based Virtual Screening of New Sodium Glucose Cotransporter Type 2 Inhibitors
inferred← citeshttps://doi.org/10.29228/jrp.128openalex-snapshot
Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model
inferred← citeshttps://doi.org/10.33250/16.03.147openalex-snapshot
Порівняльні психотропні та знеболювальні властивості інгібіторів натрійзалежного котранспортера глюкози 2 типу (SGLT2) дапагліфлозину й емпагліфлозину
inferred← citeshttps://doi.org/10.33263/briac116.1417314184openalex-snapshot
In silico Screening and Identification of Natural Compound Sophoraflavanone G as Potential Human Sodium-Glucose Cotransporter 2 Inhibitor
inferred← citeshttps://doi.org/10.33483/jfpau.1487011openalex-snapshot
İNSÜLİN DİRENCİ VE ALZHEİMER HASTALIĞI ARASINDAKİ PATOJENİK BAĞLANTI: FARMAKOLOJİK MÜDAHALELER
inferred← citeshttps://doi.org/10.3389/fendo.2022.968478openalex-snapshot
The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials
inferred← citeshttps://doi.org/10.3389/fnagi.2022.955461openalex-snapshot
Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease
inferred← citeshttps://doi.org/10.3390/biomedicines12122783openalex-snapshot
The Promising Potency of Sodium–Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients
inferred← citeshttps://doi.org/10.3390/ijms23126542openalex-snapshot
The Effectiveness of Antidiabetic Drugs in Treating Dementia: A Peek into Pharmacological and Pharmacokinetic Properties
inferred← citeshttps://doi.org/10.3390/molecules26237213openalex-snapshot
Neuroprotective Effect of SGLT2 Inhibitors
inferred← citeshttps://doi.org/10.3390/molecules27217174openalex-snapshot
Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder
inferred← citeshttps://doi.org/10.3390/ph13110379openalex-snapshot
Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury
inferred← citeshttps://doi.org/10.3390/ph16050769openalex-snapshot
Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole Action
inferred← citeshttps://doi.org/10.3390/ph16121714openalex-snapshot
Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.3390/ph19010166openalex-snapshot
Neuroprotective Potential of SGLT2 Inhibitors in Animal Models of Alzheimer’s Disease and Type 2 Diabetes Mellitus: A Systematic Review
inferred← citeshttps://doi.org/10.37882/2223-2966.2021.11.10openalex-snapshot
Ингибиторы натрий-глюкозного котранспортера способны положительно влиять на состояние головного мозга
inferred← citeshttps://doi.org/10.4314/tjpr.v19i5.20openalex-snapshot
Molecular interaction of 4-amino-N’-(benzoyloxy)-N-(2,4- dimethylphenyl)-1,2,5-oxadiazole-3-carboximidamide with the methotrexate binding site of human DHFR, and its implication in rheumatoid arthritis
inferred← citeshttps://doi.org/10.6084/m9.figshare.12096507openalex-snapshot
Additional file 1 of Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.